Roivant Sciences Ltd. (ROIV)
NCM · Common · CUSIP G76279101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ROIV and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G76279101
Market Cap
Large Cap
IPO
10/7/2020
Previous Symbol
MAAC (changed 9/30/2021)
Previous Name
Montes Archimedes Acquisition Corp
Business: Roivant Sciences Ltd.focuses on improving the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants – nimble and focused biopharmaceutical and health technology companies.
Notes: Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment.

Company Contact

CEO
Matthew Gline
CFO
Richard Pulik
Investor Relations
ir@roivant.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
Find all related securities for ROIV »